Cargando…

Monotherapy with amlodipine or hydrochlorothiazide in patients with mild to moderate hypertension: Comparison of their efficacy and effects on electrolytes

BACKGROUND: Amlodipine and hydrochlorothiazide (HCTZ) are commonly prescribed in Nigeria either as a monotherapy or in combination with other drugs. The present study was designed to investigate the antihypertensive efficacy of monotherapy with amlodipine or HCTZ and their effects on electrolyte pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nwachukwu, Daniel C, Eze, Anthonius A, Nwachukwu, Nkiru Z, Aneke, Eddy I, Agu, Polycarp U, Azubike, Nkiru C, Obika, Leonard FO, Okoye, Onochie I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Medical Association Of Malawi 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610279/ https://www.ncbi.nlm.nih.gov/pubmed/28955416

Ejemplares similares

Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril
por: Nwachukwu, Daniel Chukwu, et al.
Publicado: (2015)

Visual acuity and refractive changes among pregnant women in Enugu, Southeast Nigeria
por: Nkiru, Z. Nwachukwu, et al.
Publicado: (2018)

Losartan/Hydrochlorothiazide Fixed Combination Versus Amlodipine Monotherapy in Korean Patients With Mild to Moderate Hypertension
por: Chung, Jin-Wook, et al.
Publicado: (2009)

Must we remain blind to undergraduate medical ethics education in Africa? A cross-sectional study of Nigerian medical students
por: Okoye, Onochie, et al.
Publicado: (2017)

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010)

Determinants of participation in glaucoma genomic research in South East Nigeria: A cross-sectional analytical study
por: Uche, Nkechinyere J., et al.
Publicado: (2023)

Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
por: Jonnalagadda, Venu Gopal, et al.
Publicado: (2017)

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis
por: Roth, Eli M., et al.
Publicado: (2013)

Spectrophotometric and HPLC Methods for Simultaneous Estimation of Amlodipine Besilate, Losartan Potassium and Hydrochlorothiazide in Tablets
por: Wankhede, S. B., et al.
Publicado: (2010)

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update
por: Destro, Maurizio, et al.
Publicado: (2010)

Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure
por: Doménech, Monica, et al.
Publicado: (2010)

Estimation of Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Bulk Mixture and Tablet by UV Spectrophotometry
por: Galande, Varsha R., et al.
Publicado: (2012)

Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
por: Simonyi, Gábor, et al.
Publicado: (2016)

Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy
por: Punzi, Henry, et al.
Publicado: (2012)

Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
por: Hovater, Michael B, et al.
Publicado: (2013)

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
por: Bramlage, Peter, et al.
Publicado: (2014)

Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review
por: Johnson, Rabia, et al.
Publicado: (2019)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Knowledge and attitude of donating and using cord blood for transfusion among patients attending Nnamdi Azikiwe University Teaching Hospital, Nnewi, South East Nigeria
por: Okocha, Chide E., et al.
Publicado: (2017)

A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
por: Segura, Julian, et al.
Publicado: (2013)

A Comparative Study of the Management of Stage 2 hypertension by Combined therapy with Losartan, Amlodipine and Hydrochlorothiazide
por: Jafarzadeh Esfehani, Reza, et al.
Publicado: (2012)

Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects
por: Jung, Jihyun, et al.
Publicado: (2021)

Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual‐Combination Therapy
por: Rump, Lars C., et al.
Publicado: (2015)

Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorothiazide, among Palestinian hypertensive patients
por: Zaid, Abdel Naser, et al.
Publicado: (2016)

Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC–ESI-MS/MS and its application to pharmacokinetics in rats
por: Gadepalli, Shankar Ganesh, et al.
Publicado: (2014)

Application of an LC–MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study
por: Shah, Jaivik V., et al.
Publicado: (2017)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
por: Jo, Sang-Ho, et al.
Publicado: (2018)

Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age
por: Lewin, Andrew J., et al.
Publicado: (2013)

Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study
por: Hagendorff, Andreas, et al.
Publicado: (2014)

Central Composite Design for Validation of HPTLC Method for Simultaneous Estimation of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Tablets
por: Solanki, Trupti B., et al.
Publicado: (2014)

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
por: Rhee, Moo-Yong, et al.
Publicado: (2015)

Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
por: Sung, Jidong, et al.
Publicado: (2016)

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension
por: Lacourcière, Y, et al.
Publicado: (2011)

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
por: Laffer, Cheryl L, et al.
Publicado: (2011)

Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
por: Stafylas, Panagiotis, et al.
Publicado: (2015)

Response surface analyses of antihypertensive effects of angiotensin receptor blockers and amlodipine or hydrochlorothiazide combination therapy in patients with essential hypertension
por: Cho, Minhee, et al.
Publicado: (2023)

Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
por: Seki, Yasufumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h0iods0u4r3bm32fdqe5kku04i